$68.02
-1.92 (-2.75%)
At Close: Jul 31, 2026
GE HealthCare Management to Present at 42nd Annual J.P. Morgan Healthcare Conference
08:51am, Monday, 18'th Dec 2023
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and Chief Financial Officer, Jay Saccaro, will
Artificial Intelligence in Healthcare: 3 Stocks Transforming the Industry
08:01am, Monday, 11'th Dec 2023
Artificial intelligence is being applied across the healthcare sector to improve delivery overall. AI stocks have the potential to impact stock sectors across the market positively, and healthcare is
GE HealthCare Technologies Remains Ridiculously Undervalued
03:28am, Sunday, 10'th Dec 2023
GE HealthCare Technologies has underperformed the market since July, down 16% while the S&P 500 has increased by 0.6%. The company's revenue has grown in its PDx, PCS, and Imaging segments, but net in
S&P 500 Gains and Losses Today: GE HealthCare Technologies Downgraded
05:20pm, Monday, 27'th Nov 2023
U.S. equities fell to open the new trading week ahead of the release of the Fed's favorite measure of inflation, which could give hints as to where interest rates are heading. The S&P 500 dropped 0.2%
UBS downgrades GE HealthCare to sell
02:00pm, Monday, 27'th Nov 2023
The "Halftime Report" traders debate the biggest analyst calls of the day
Midday Movers: GE HealthCare Slumps, Crown Castle Advances
12:20pm, Monday, 27'th Nov 2023
U.S. equities were mixed and little changed at midday Monday ahead of key inflation data due later in the week. The Dow and S&P 500 lost ground, while the Nasdaq was in the green.
GE HealthCare's stock slides premarket after UBS downgrade to sell
06:12am, Monday, 27'th Nov 2023
GE HealthCare Technologies Inc.'s stock GEHC fell 2.8% in premarket trade Monday, after UBS downgraded the stock to sell from neutral and cut its price target to $66 from $86. Analysts led by Graham D
GE HealthCare Technologies Inc. (GEHC) Q3 2023 Earnings Call Transcript
10:19am, Friday, 03'rd Nov 2023
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM ET Company Participants Carolynne Borders - Head-Investor Relations Peter Arduini - President &
GE HealthCare's Results Beat Estimates on Higher Demand for Medical Equipment
05:05pm, Tuesday, 31'st Oct 2023
A jump in elective surgeries delayed during the COVID-19 pandemic boosted demand for medical equipment made by GE HealthCare Technologies (GEHC), and shares advanced.
Final Trades: Cleveland-Cliffs, Arista Networks & more
02:05pm, Tuesday, 31'st Oct 2023
The "Halftime Report" traders give their top picks to watch for the second half.
GE HealthCare stock rallies on 3Q earnings beat
11:47am, Tuesday, 31'st Oct 2023
GE HealthCare Technologies has posted third-quarter earnings that beat expectations and revised its full-year guidance, sending its shares higher on Tuesday. The Chicago-based medical devices company,
GE HealthCare beats quarterly profit estimates on imaging device demand
07:40am, Tuesday, 31'st Oct 2023
GE HealthCare Technologies Inc on Tuesday beat Wall Street expectations for third-quarter profit as a continued recovery in demand for surgical procedures boosted sales of its medical devices.
GE HealthCare beats Q3 profit estimates
06:32am, Tuesday, 31'st Oct 2023
GE HealthCare Technologies Inc. GEHC, +0.11% said Tuesday it had net income of $375 million, or 83 cents a share, for the third quarter, down from $487 million, or $1.07 a share, in the year-earlier p
GE HealthCare (GEHC) to Report Q3 Earnings: What's in Store?
12:47pm, Friday, 20'th Oct 2023
GE HealthCare (GEHC) is expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.
GE HealthCare teams up with Novo Nordisk to treat diabetes without drugs
08:36am, Thursday, 19'th Oct 2023
GE HealthCare Technologies Inc. GEHC, -2.35% on Thursday said it is teaming up with Novo Nordisk NVO, -0.58% to develop an ultrasound treatment for type 2 diabetes and obesity.
Sign In
Buy GEHC